Real-world one year outcomes of a switch to aflibercept from ranibizumab in neovascular age related macular degeneration

被引：0
|
作者：
Citu, Maria Cristina [1 ,2 ]
Crosby-Nwaobi, Roxanne R. [1 ,2 ]
Eleftheriadou, Maria [1 ,2 ]
Vazquez-Alfageme, Clara [1 ,2 ]
Nicholson, Luke [1 ,2 ]
Sivaprasad, Sobha [1 ,2 ]
Hykin, Philip [1 ,2 ]
Hamilton, Robin D. [1 ,2 ]
机构：
[1] Moorfields Eye Hosp, NIHR Biomed Res Ctr, London, England
[2] UCL, Inst Ophthalmol, London, England
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2016年 / 57卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3342
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Switching to Aflibercept in Ranibizumab Refractory Age-Related Macular Degeneration: a Real-World Experience from Sweden
    Mejaddam, Assem
    Rosso, Aldana
    Westborg, Inger
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [22] Reply to: 'Comment on: 'One-year real-world outcomes in patients receiving fixed-dosing aflibercept for neovascular age-related macular degeneration'
    Almuhtaseb, H.
    Lotery, A.
    [J]. EYE, 2018, 32 (02) : 479 - 481
  • [23] Reply to: ‘Comment on: ‘One-year real-world outcomes in patients receiving fixed-dosing aflibercept for neovascular age-related macular degeneration’
    H Almuhtaseb
    A Lotery
    [J]. Eye, 2018, 32 : 479 - 481
  • [24] 3 years real-world treatment outcomes of ranibizumab vs aflibercept for neovascular age-related macular degeneration: Data from the fight retinal blindness! registry
    Bhandari, Sanjeeb
    Vuong Nguyen
    Arnold, Jennifer
    Young, Stephanie
    Banerjee, Gayatri
    Gillies, Mark
    Barthelmes, Daniel
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 47 : 69 - 69
  • [25] Results of the switch from Intravitreal Ranibizumab to Intravitreal Aflibercept Therapy in Patients with Neovascular Age-Related Macular Degeneration: A 42-month Retrospective Real-World Study
    Ertan, E.
    Efe, N.
    Sabaner, M. C.
    Dogan, M.
    [J]. NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2021, 24 (12) : 1824 - 1827
  • [26] Ranibizumab in patients with neovascular age-related macular degeneration: results from the real-world LUMINOUS™ study
    Souied, E.
    Clemens, A.
    Macfadden, W.
    [J]. ACTA OPHTHALMOLOGICA, 2017, 95
  • [27] One-Year Outcomes of Aflibercept in Recurrent or Persistent Neovascular Age-Related Macular Degeneration
    Arcinue, Cheryl A.
    Ma, Feiyan
    Barteselli, Giulio
    Sharpsten, Lucie
    Gomez, Maria Laura
    Freeman, William R.
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2015, 159 (03) : 426 - 436
  • [28] One-Year Outcomes of Aflibercept in Recurrent or Persistent Neovascular Age-Related Macular Degeneration
    Iacono, Pierluigi
    Parodi, Maurizio Battaglia
    Bandello, Francesco
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2015, 159 (05) : 996 - 997
  • [29] Real-world outcomes for fellow eyes in neovascular age-related macular degeneration
    Aydogmus, Fatma Sema Akkan
    Onwuka, Oluchukwu
    Saddemi, Jackson
    Lasalle, Claudia
    Ramsey, David J.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [30] Real-world treatment outcomes of neovascular Age-related Macular Degeneration in the Netherlands
    Verbraak, Frank D.
    Ponsioen, Dirk L.
    Tigchelaar-Besling, Odette A. M.
    Nguyen, Vuong
    Gillies, Mark C.
    Barthelmes, Daniel
    Klaver, Caroline C. W.
    [J]. ACTA OPHTHALMOLOGICA, 2021, 99 (06) : E884 - E892
12345